Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PROCEPT BioRobotics Corp Director's Dealing 2023

Apr 12, 2023

31665_dirs_2023-04-12_b8799760-fcee-4666-af72-8f9b12ad763d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PROCEPT BioRobotics Corp (PRCT)
CIK: 0001588978
Period of Report: 2023-04-11

Reporting Person: Shiblaq Hisham (EVP, Chief Comm. Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-04-11 Common Stock S 21930 $35.2264 Disposed 31414 Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 9, 2022.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35 to $35.44, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.